These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38843940)

  • 21. Gene therapy: the case for cystic fibrosis.
    Alton EW; Geddes D
    J R Soc Med; 1997; 90 Suppl 31(Suppl 31):43-6. PubMed ID: 9204011
    [No Abstract]   [Full Text] [Related]  

  • 22. Making precision medicine personal for cystic fibrosis.
    Manfredi C; Tindall JM; Hong JS; Sorscher EJ
    Science; 2019 Jul; 365(6450):220-221. PubMed ID: 31320522
    [No Abstract]   [Full Text] [Related]  

  • 23. A new era in the treatment of cystic fibrosis.
    Lane MA; Doe SJ
    Clin Med (Lond); 2014 Feb; 14(1):76-8. PubMed ID: 24532752
    [No Abstract]   [Full Text] [Related]  

  • 24. Gene therapy for cystic fibrosis.
    Davies JC; Geddes DM; Alton EW
    J Gene Med; 2001; 3(5):409-17. PubMed ID: 11601754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How do cystic fibrosis transmembrane conductance regulator mutations produce lung disease?
    Pilewski JM; Frizzell RA
    Curr Opin Pulm Med; 1995 Nov; 1(6):435-43. PubMed ID: 9363079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond cystic fibrosis transmembrane conductance regulator therapy: a perspective on gene therapy and small molecule treatment for cystic fibrosis.
    Schneider-Futschik EK
    Gene Ther; 2019 Sep; 26(9):354-362. PubMed ID: 31300729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gene therapy research in cystic fibrosis--lessons from early clinical studies].
    Coutelle C
    Pneumologie; 1996 Dec; 50 Suppl 3():865-6. PubMed ID: 9157444
    [No Abstract]   [Full Text] [Related]  

  • 28. Cystic fibrosis transmembrane conductance regulator biomarkers in 'real life': can we evaluate individual efficacy of cystic fibrosis transmembrane conductance regulator therapy?
    van Koningsbruggen-Rietschel S; Naehrlich L
    Ther Adv Respir Dis; 2015 Aug; 9(4):198-200. PubMed ID: 26175480
    [No Abstract]   [Full Text] [Related]  

  • 29. Breathing Easier: Molecular Therapeutics for Cystic Fibrosis.
    Limberis MP
    Hum Gene Ther; 2020 Sep; 31(17-18):905-906. PubMed ID: 32945723
    [No Abstract]   [Full Text] [Related]  

  • 30. Gene transfer for cystic fibrosis.
    Welsh MJ
    J Clin Invest; 1999 Nov; 104(9):1165-6. PubMed ID: 10545512
    [No Abstract]   [Full Text] [Related]  

  • 31. Emerging technologies for cystic fibrosis transmembrane conductance regulator restoration in all people with CF.
    Egan ME
    Pediatr Pulmonol; 2021 Feb; 56 Suppl 1(Suppl 1):S32-S39. PubMed ID: 32681713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis.
    Alton EW; Boyd AC; Cheng SH; Cunningham S; Davies JC; Gill DR; Griesenbach U; Higgins T; Hyde SC; Innes JA; Murray GD; Porteous DJ
    Thorax; 2013 Nov; 68(11):1075-7. PubMed ID: 23525080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innovations in the treatment of cystic fibrosis: outriders for the treatment of diseases with other genetic defects?
    Schubert-Zsilavecz M; Merk D
    Future Med Chem; 2011 Dec; 3(16):1969-70. PubMed ID: 22098344
    [No Abstract]   [Full Text] [Related]  

  • 34. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Lee T; Southern KW
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005599. PubMed ID: 17443603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Lee TW; Southern KW
    Cochrane Database Syst Rev; 2012 Oct; 10():CD005599. PubMed ID: 23076917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Lee TW; Southern KW
    Cochrane Database Syst Rev; 2013 Nov; (11):CD005599. PubMed ID: 24282073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The implications and management of cystic fibrosis screen positive, inconclusive diagnosis patients.
    Krishnananthan T; Pao C
    Paediatr Respir Rev; 2019 Aug; 31():21-24. PubMed ID: 31153793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Personalised medicine for cystic fibrosis: treating the basic defect.
    Elborn JS
    Eur Respir Rev; 2013 Mar; 22(127):3-5. PubMed ID: 23457158
    [No Abstract]   [Full Text] [Related]  

  • 39. Gene therapy for cystic fibrosis: challenges and future directions.
    Wilson JM
    J Clin Invest; 1995 Dec; 96(6):2547-54. PubMed ID: 8675618
    [No Abstract]   [Full Text] [Related]  

  • 40. [New therapeutic approaches to Cystic fibrosis].
    Willemot JM; Sermet Gaudelus I; Lenoir G
    Ann Pharm Fr; 2003 Jul; 61(4):253-8. PubMed ID: 12843958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.